Is ONC or ONCY more undervalued in 2026?

CirclFi compares BeOne Medicines Ltd. (ONC) and Oncolytics Biotech Inc. (ONCY) using 13 institutional-grade valuation models. ONC has a Quality of Company score of 9.7/10 while ONCY scores 3.4/10.

Which is a better buy — ONC or ONCY?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ONC and ONCY valuations compare?

ONC at $290.58 and ONCY at $0.94 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ONC vs ONCY Valuation Comparison 2026 — Intrinsic Value Analysis

ONC

Biotechnology

BeOne Medicines Ltd.

Quality

9.7

out of 10

Value Trap

SAFE

Price

$290.58

Last close

Models

13/13

Active

ONCY

Biotechnology

Oncolytics Biotech Inc.

Quality

3.4

out of 10

Value Trap

—

Price

$0.94

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	ONC Fair Value	ONC Upside	ONCY Fair Value	ONCY Upside
Bayesian DCF	Intrinsic	$179.01	-38.4%	$0.27	-70.9%
Earnings Power Value	Intrinsic	$67.55	-76.8%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$54.94	-81.1%	$0.16	-82.7%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ONC vs ONCY — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ONC vs ONCY — Which Stock Is More Undervalued?

ONC scores higher with a 9.7/10 quality rating vs ONCY's 3.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing BeOne Medicines Ltd. (ONC) and Oncolytics Biotech Inc. (ONCY) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ONC currently trades at $290.58 with a QOC of 9.7/10, while ONCY trades at $0.94 with a QOC of 3.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).